# Algorithmic antibiotic decision-making in urinary tract infection using prescriber-informed prediction of treatment utility

**Authors:** Alex Howard, Peter L. Green, Yinzheng Zhong, David M. Hughes, Alessandro Gerada, Simon Maskell, Anoop Velluva, Iain E. Buchan, William Hope

PMC · DOI: 10.1038/s41746-026-02369-z · NPJ Digital Medicine · 2026-01-26

## TL;DR

This paper introduces an algorithm that combines data and clinician input to improve antibiotic prescribing for urinary tract infections.

## Contribution

The novel approach integrates clinician judgment with data-driven predictions to guide antibiotic decisions.

## Key findings

- The algorithm selected more correctly-targeted WHO Access category antibiotics than human prescribers.
- It also chose more oral antibiotics and fewer intravenous ones compared to human decisions.
- The results suggest the algorithm could improve antibiotic prescribing by combining human and data-driven insights.

## Abstract

Predicting antibiotic treatment outcomes could help tackle antibiotic resistance by guiding prescribing decisions. Existing approaches do not quantitatively incorporate the judgment of clinician users. Our antibiotic decision-making algorithm predicted treatment outcomes for 13 antibiotics using clinical prediction models trained on prescribing and urine culture data from 93,906 patients, then weighted outcomes using treatment decisions made by 49 clinicians in an antibiotic choice ranking exercise. In a simulation using Emergency Department data, the algorithm chose more correctly-targeted World Health Organization Access category antibiotics (75.6% of cases versus 11.9%, 95% confidence interval of difference 57.6% to 69.7%, p < 0.001) and oral antibiotics (69% versus 22.6%, 95% confidence interval of difference 39.5% to 53.4%, p < 0.001) than human prescribers, and fewer intravenous antibiotics (31.2% versus 65.8%, 95% confidence interval of difference −41.9% to −27.1%, p < 0.001). These results show that our algorithm could improve antibiotic prescribing decisions by combining human judgment with data-driven probability predictions.

## Linked entities

- **Diseases:** urinary tract infection (MONDO:0005247)

## Full-text entities

- **Diseases:** Infection (MESH:D007239), C. difficile infection (MESH:D003015), weakness (MESH:D018908), pyelonephritis (MESH:D011704), infectious diseases (MESH:D003141), urinary tract infection (MESH:D014552), respiratory (MESH:D012131), nephrotoxic drugs (MESH:D000081015), sepsis (MESH:D018805), urinary disease (MESH:D014570), presyncope (MESH:D013575), acute kidney injury (MESH:D058186), nausea (MESH:D009325), thrombocytopenia (MESH:D013921), allergic (MESH:D004342), MIMIC-IV (MESH:D006011), leukopenia (MESH:D007970), antibiotic (MESH:D004761), cytotoxic drugs (MESH:D000092582), deranged liver function (MESH:D056486), AMR (MESH:D060467), bacteriuria (MESH:D001437), marrow suppression (MESH:D001855), death (MESH:D003643), drug toxicity (MESH:D064420), chronic liver disease (MESH:D008107), anaemia (MESH:D000743), delirium (MESH:D003693), vomiting (MESH:D014839), lethargy (MESH:D053609), tachycardia (MESH:D013610), bleeding (MESH:D006470), hypotension (MESH:D007022), cystitis (MESH:D003556)
- **Chemicals:** cefepime (MESH:D000077723), Cefazolin (MESH:D002437), meropenem (MESH:D000077731), ceftriaxone (MESH:D002443), BioRender (-), ampicillin (MESH:D000667), gentamicin (MESH:D005839), ceftazidime (MESH:D002442), trimethoprim-sulfamethoxazole (MESH:D015662), piperacillin-tazobactam (MESH:D000077725), creatinine (MESH:D003404), ampicillin-sulbactam (MESH:C035444), ciprofloxacin (MESH:D002939), Nitrofurantoin (MESH:D009582), aspartate (MESH:D001224), Vancomycin (MESH:D014640)
- **Species:** Pseudomonas (RNA similarity group I, genus) [taxon 286], Escherichia coli (E. coli, species) [taxon 562], Klebsiella pneumoniae (species) [taxon 573], Enterococcus faecium (species) [taxon 1352], Clostridioides difficile (species) [taxon 1496], Homo sapiens (human, species) [taxon 9606], Enterobacterales (order) [taxon 91347]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12882935/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12882935/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12882935/full.md

---
Source: https://tomesphere.com/paper/PMC12882935